
News • Dual targeting radioligand
“Smart missile” radiopharmaceutical shows promise against multiple cancers
New research makes a strong case for a new dual-targeting radiopharmaceutical, designed to attach to two vulnerable sites on cancer cells, enabling more precise and potent therapy.